Skip to main content
Premium Trial:

Request an Annual Quote

Beckman, Immune Tolerance Network Open Cell-based Assay Core Lab

NEW YORK, Sept. 27 (GenomeWeb News) - Beckman Coulter and the Immune Tolerance Network have opened a core laboratory to develop, standardize, and automate cell-based tests for clinical trials at Beckman's facility in Miami, the company said today.

 

Researchers from ITN, Beckman, and investigators from the USand Europeplan to develop and validate new cellular assays of T-cell responses for monitoring immune tolerance in clinical trials. "We believe that Beckman Coulter has a special expertise in these areas and look forward to working with the company in developing a number of these assays," said Hugh Auchincloss, chief operating officer of ITN, in a statement.

 

The Immune Tolerance Network, based at the Universityof California, San Francisco, is an international research collaboration with a dozen core facilities.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.